Animal Health: With a primary focus on biologicals, feed additives and veterinary diagnostics
A strategic focus
Along with Agritech more generally, animal health is a primary areas of focus reflected in the overall number of clients and projects completed each year. We work with many of the leading animal health research institutes and universities globally, supporting ad hoc projects through to longer term business development and IP support.
Broad technology expertise
Our expertise covers veterinary medicines, particularly vaccines, and veterinary diagnostics, both laboratory based and point-of care diagnostics. With a primary focus on production animals, we also undertake projects relating to companion animals (dogs, cats and horses) and aquaculture.
Extensive industry contacts
The animal health industry is more fragmented and generally less well understood than the much larger human health market. We routinely meet with and have good personal contacts across the major players and tier 2 companies in different parts of the sector (medicines, feed, diagnostics etc.), using these connections to be able to rapidly understand changes in their business focus and technology interests.
Industry Sector Lead:
Rupert Osborn
Managing Director
+44 (0)203 176 0584
rupert.osborn@ip-pragmatics.com
Recent Projects
- Working with a leading UK animal viral research institute to provide in house IP management and business development support, including undertaking an audit of commercial opportunities and devising a strategy to take these forward.
- Assisting a leading Russell Group university to a review the commercial opportunities in animal health from its research base across different departments including its veterinary sciences department.
- Undertaking a BBSC Pathfinder funded market assessment and patent landscape for a novel diagnostic for kidney disease in cats.
Recent Projects
- Negotiating and finalising a multi-million Euro vaccine development and licence agreement to develop new blue tongue vaccines. This also involved the separate negotiation of a major licence agreement with our client and a South African partner.
- Licensing a new vaccine adjuvant technology to a major US animal health company.
- Option agreement and subsequent licensing of novel respiratory pig vaccine with a major US animal health company.
- £3m secured for a UK university client for a novel vaccine development.
Recent Projects
- Licensing and collaboration between a Chinese company and a UK government client to market and sell their animal reagents across China.
- Development by a UK government client of a new animal diagnostic funded by a Chinese company.
- Project management of a 4-year £3 million Wellcome Trust funded project to develop novel foot and mouth disease vaccines.
- Undertaking a review across Scotland for Scottish Enterprise of the capabilities and options to create a ‘One Health’ network.
Project Outcomes
- Providing a market assessment and patent landscape for a UK university investigating the opportunity for novel anti-viral therapeutics in cattle leading to the university securing significant additional translational funding.
- Assisting with the marketing and sales strategies for a major veterinary proficiency testing service leading to a more than 50% growth in their revenues over a 5-year period.
- Provision of resources to the UK Trade & Investment’s (UKTI) R&D Programme in the animal health sectors leading to a number of new investment opportunities into UK from global animal health and veterinary diagnostic companies.
- Assisting a UK research organisation to negotiate and complete the sale of a molecular array product business to a global leading diagnostic company resulting in significant revenue to the organisation.
- Undertaking an IP audit for a veterinary practise leading to the company implementing improved procedures to identify and manage their intellectual property assets.
- Assisting a UK client to identify and secure seed funding to develop a range of molecular infectious disease assays and subsequently assisting the development and execution of a strategic agreement with a global diagnostic company.
